Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)

Go back to Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)
(NASDAQ: BBOT) Delayed: 8.56 +0.25 (3.01%)
Previous Close $8.31    52 Week High
Open $8.26    52 Week Low
Day High $8.61    P/E N/A 
Day Low $7.94    EPS
Volume 269,659